Literature DB >> 1850046

Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene.

J C Lin1, N D Sista, F Besençon, J Kamine, J S Pagano.   

Abstract

In order to identify the gene encoding the Epstein-Barr virus (EBV) DNA polymerase, a portion of the BamHI-A fragment containing the fifth leftward open reading frame (BALF5) of the EBV genome was cloned into SP6 and T7 promoter-containing vectors for in vitro transcription-translation. The RNA synthesized in vitro was used to program rabbit reticulocyte lysates, which were analyzed for the synthesis of the putative polymerase polypeptide (110 kDa) and assayed directly for EBV DNA polymerase activity. The polypeptide synthesized by the full-length BALF5 genomic fragment had a molecular mass of 110 kDa. 5'-truncated BALF5 with the first and second ATGs deleted produced 95- and 83-kDa polypeptides, respectively. All three translation products were enzymatically active and displayed resistance to high salt concentrations. The identity of the largest polypeptide as the viral polymerase was established by (i) immunoprecipitation with EBV-positive sera from patients with nasopharyngeal carcinoma and by a rabbit polyclonal antiserum prepared with a synthetic peptide derived from the DNA sequence of BALF5; (ii) identification of a polypeptide of identical size (110 kDa) immunoprecipitated from superinfected Raji cell extracts by these antibodies; and (iii) salt-resistant enzymatic activity which was neutralized by the rabbit EBV antiserum. Thus, BALF5 encodes a functional polymerase identical to that induced in superinfected Raji cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850046      PMCID: PMC240638     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Translational regulation of herpes simplex virus DNA polymerase.

Authors:  D R Yager; A I Marcy; D M Coen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase gene.

Authors:  D I Dorsky; C S Crumpacker
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Isolation and characterization of herpes simplex virus mutants containing engineered mutations at the DNA polymerase locus.

Authors:  A I Marcy; D R Yager; D M Coen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.

Authors:  J C Lin; M C Smith; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

Review 5.  Cellular transformation by the herpesviruses and antiviral drugs.

Authors:  J C Lin; J S Pagano
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

6.  Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus.

Authors:  R J Feighny; B E Henry; A K Datta; J S Pagano
Journal:  Virology       Date:  1980-12       Impact factor: 3.616

7.  Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.

Authors:  J C Lin; H Machida
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

8.  Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activity.

Authors:  D I Dorsky; C S Crumpacker
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.

Authors:  J C Lin; M C Smith; J S Pagano
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

10.  Acyclovir inhibition of Epstein-Barr virus replication.

Authors:  A K Datta; B M Colby; J E Shaw; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  16 in total

1.  Regulation of the Epstein-Barr virus DNA polymerase gene.

Authors:  F B Furnari; M D Adams; J S Pagano
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.

Authors:  K J Gilligan; P Rajadurai; J C Lin; P Busson; M Abdel-Hamid; U Prasad; T Tursz; N Raab-Traub
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis.

Authors:  T R Serio; J L Kolman; G Miller
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.

Authors:  J C Lin; E De Clercq; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit.

Authors:  T Tsurumi; A Kobayashi; K Tamai; T Daikoku; R Kurachi; Y Nishiyama
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro.

Authors:  T Tsurumi; T Daikoku; R Kurachi; Y Nishiyama
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Functional characterization of partially purified Epstein-Barr virus DNA polymerase expressed in the baculovirus system.

Authors:  J C Lin; B K De; E C Mar
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Role of the TSG101 gene in Epstein-Barr virus late gene transcription.

Authors:  Huey-Huey Chua; Heng-Huan Lee; Shih-Shin Chang; Chih-Chung Lu; Te-Huei Yeh; Tsuey-Ying Hsu; Tzu-Hao Cheng; Jiin-Tsuey Cheng; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

9.  The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.

Authors:  Qiao Meng; Stacy R Hagemeier; Joyce D Fingeroth; Edward Gershburg; Joseph S Pagano; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

10.  trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.